Orthocell’s Paul Anderson spoke with Alisha Newell at Proactive Investors to discuss the Company’s strong position following the recently executed global exclusive licence and distribution agreement with BioHorizons Implant Systems Inc for $OCC’s Striate+™ dental membrane.
